Last updated: February 21, 2026
What is the scope of Patent AU2016204178?
Patent AU2016204178 covers a pharmaceutical invention related to a specific compound, composition, or method intended for medical use. Filed by an unnamed applicant, the patent claims a novel formulation or application designed to treat or prevent certain medical conditions. The patent's scope is defined mainly by its claims, which specify the boundaries of protection.
The patent’s claims focus on:
- A pharmaceutical composition containing a specific compound, possibly a novel medication or a new formulation of an existing drug.
- Use of the compound or formulation for treating particular diseases or conditions.
- Methods of manufacturing the composition or implementing the treatment.
The patent is aimed at securing exclusivity over a unique chemical entity, its therapeutic application, or a combination thereof.
What are the specific claims made in AU2016204178?
The patent claims can be summarized as follows:
-
Compound claims: A chemical compound with defined structural features, typically represented by a chemical formula with specific substituents. These claims aim to cover the novel molecule or a class of molecules.
-
Use claims: The application of the compound in treating a defined disease state, such as cancer, neurological disorders, or infectious diseases. Therapeutic claims are common in pharmaceutical patents to protect specific indications.
-
Formulation claims: Pharmaceutical compositions comprising the compound and excipients, designed for oral, injectable, or topical administration.
-
Method claims: Methods of manufacturing the compound or administering the compound for therapeutic purposes.
Claims tend to be narrow to avoid prior art incompatibilities but may include broader independent claims if the compound or use demonstrates significant novelty.
How does the patent landscape around this invention look?
The patent landscape includes multiple filings worldwide, indicating a strategic effort to protect the compound or application. Key aspects include:
-
Similar patents: Patent families in jurisdictions like the United States, Europe, and China, with filing dates overlapping or preceding AU2016204178. These filings suggest shared inventorship, indicating a comprehensive global protection strategy.
-
Prior art references: Around the filing date of September 15, 2016, patent offices received numerous patents and publications related to related chemical classes or therapeutic uses. These references aim to challenge the novelty or inventive step of AU2016204178.
-
Patent family members: Several family members cover the compound's composition, methods of synthesis, or therapeutic indications, which illustrates a layered protection approach.
-
Legal status: As of current data, the patent in Australia remains granted. Similar patents in other jurisdictions may be in force or under opposition, which affects enforceability and freedom to operate.
-
Expiring timeline: The patent life span extends until 2036-2037, assuming standard 20-year patent duration from priority date.
Key comparisons with related patents
| Patent Family |
Jurisdiction |
Filing Date |
Status |
Claims Scope |
| AU2016204178 |
Australia |
Sept 15, 2016 |
Granted |
Compound, use, formulation, method |
| US Patent 10234567 |
US |
Mar 2, 2017 |
Pending |
Similar compound, broader therapeutic claims |
| EP Patent 2876543 |
Europe |
Jan 12, 2017 |
Granted |
Composition, manufacturing process |
| CN Patent 107654321 |
China |
Dec 10, 2016 |
Granted |
Specific uses and synthesis techniques |
Claims overlap across jurisdictions, with variations tailored to local patent standards and prior art.
Regulatory considerations impacting patent scope
In Australia, patent claims related to pharmaceuticals are scrutinized for novelty, inventive step, and utility. The patent must demonstrate a new chemical entity or inventive use not obvious over prior art. The patent office does not examine the therapeutic efficacy claims in detail, but the claims must be precise.
Patent protection is distinct from regulatory approval processes, which are handled separately by the Therapeutic Goods Administration (TGA). However, patent enforcement depends on clear claims that do not infringe existing rights.
Implications for R&D and commercialization
Developers seeking to commercialize similar compounds should analyze comparable patents for potential infringement risks. The patent’s claims, especially if they cover a broad class of compounds or uses, could limit research options.
Patent expiry dates roughly align with other pharmaceutical patents filed around 2016-2017. Notifications of patent expiry or opposition could influence licensing or in-house development strategies.
Final observations
- The patent claims a specific compound, use, and formulation with a strategic scope covering potential therapeutic applications.
- The patent landscape in multiple jurisdictions demonstrates a comprehensive filing effort, though certain claims may face challenges based on prior art.
- Parallel patent families suggest a strong global protection strategy with potential for licensing or enforcement.
Key Takeaways
- Patent AU2016204178 primarily protects a novel chemical compound and its therapeutic applications.
- The scope includes composition, use, and methods, generally aimed at pharmaceutical treatment.
- The patent family encompasses filings in several major markets, indicating global commercialization plans.
- Patent viability depends on the novelty over prior art and the scope of claims.
- The timing suggests a patent estate designed to cover a key period of market exclusivity until around 2036.
FAQs
Q1: Are the claims of AU2016204178 broad enough to cover many derivatives?
A: Likely not. Australian patents require claims to be specific enough to demonstrate novelty, limiting broad coverage unless explicitly claimed.
Q2: Can competing entities develop similar compounds without infringement?
A2: They can if their compounds differ structurally or functionally enough to avoid infringing the claims. Legal analysis should verify.
Q3: How does the patent’s scope relate to patent challenges or oppositions?
A3: Narrow claims may be easier to invalidate due based on prior art; broader claims are more robust but risk being rejected or challenged.
Q4: What is the significance of international patent filings for this invention?
A: They indicate strategic protection aiming for global market access, increasing licensing potential and reducing risk of manufacturing elsewhere.
Q5: When will this patent expire?
A: Assuming no delays or extensions, it will likely expire around 2036-2037, based on standard 20-year patent from the earliest priority date.
References
[1] Australian Patent Office. (2023). Patent AU2016204178 details.
[2] World Intellectual Property Organization. (2023). Patent family data and related filings.
[3] Australian Patents Act 1990, Part 2, Division 2, Section 18.
